Literature DB >> 30548554

Management of local or regional non-nodal disease.

Jennifer M Racz1, Matthew S Block2, Christian L Baum3, James W Jakub1.   

Abstract

Some melanomas develop a striking avidity for lymphatic spread. In spite of multiple recurrences, patients can remain years without visceral metastasis. There is clearly a biologic reason for this lymphotrophic pattern of growth and dissemination, which we have yet to uncover. In-transit metastases have widely diverse clinical presentations and can be a stubborn disease to cure. As a result, a host of treatments exist that should be tailored to the individual patient.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  diphenylcyclopropenone; in transit; intralesional therapy; limb perfusion; melanoma, stage III; talimogene laherparepvec

Mesh:

Year:  2018        PMID: 30548554     DOI: 10.1002/jso.25330

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  3 in total

Review 1.  Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata.

Authors:  Kun-Wei Lai; Tsen-Fang Tsai
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-22

2.  Association of tumor molecular factors with in-transit metastasis in primary cutaneous melanoma.

Authors:  James W Jakub; Amy L Weaver; Alexander Meves
Journal:  Int J Dermatol       Date:  2022-03-05       Impact factor: 3.204

3.  Surgical Resection After Talimogene Laherparepvec for Melanoma: Persistent Fuorodeoxyglucose Avidity on Positron Emission Tomography Despite No Viable Disease.

Authors:  Taleen A MacArthur; Aodhnait S Fahy; James W Jakub
Journal:  Am Surg       Date:  2021-06-01       Impact factor: 0.688

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.